https://www.selleckchem.com/ph....armacological_epigen
37-1.03]). Men who used P3P did not have a statistically significant difference in bother from urinary incontinence (3-month aOR 0.56 [95% CI 0.30-1.06]; 6-month; aOR 0.79 [95% CI 0.31-1.97]). Within the stated limitations of this study, we find that use of a decision aid for localized prostate cancer was associated with decreased odds of men being bothered from sexual dysfunction but not urinary incontinence at 6 months post prostatectomy. Within the stated limitations of this study, we find that use of a decision aid for lo
Aimer
Commentaire
Partagez
